Propeller is a smart inhaler system designed to help asthma sufferers better manage their condition by providing real-time health analytics.
This new technology has been tested in a clinical trial on 495 patients suffering from chronic asthma. As Tuesday, May 3, marks World Asthma Day, lung specialists remind sufferers that correct inhaler use plays an important role in controlling the condition.
There aren't many connected devices out there specifically targeting asthma patients. However, with almost six in 10 asthma sufferers having poor control of the condition, a high-tech device giving real-time feedback could help patients monitor and manage their treatment, pinpoint triggers and identify patterns in the aim of reducing attacks.
That's what a new intelligent inhaler system, developed by American company Propeller Health, hopes to achieve. There are three similar products currently on the market: the Nexus 6 SmartTouch, a smartphone-connected inhaler monitor; the Inspiro Medical Inspiromatic from Opko; and the CareTRx from GeckoCap, designed for children.
Propeller is an asthma management platform that uses sensors, mobile applications and location data, as well as processing algorithms to collect and analyze health data in real time. Sensors connect the inhaler to a smartphone (iOS or Android), where patients can receive notifications and advice based on real-time analytics.
Data can then be shared with a doctor or family members who can find out where the patient is if they're having an attack.
This small device was tested in a clinical trial of 495 patients suffering from chronic asthma who were monitored over a 12-month period. Participants were split into two parallel groups. All had their inhalers equipped with Propeller sensors, but only one group received electronic notifications and feedback from the insights system. Doctors of those in the connected group also had access to their patients' data. Those in the control group did not.
The results showed a reduction in the number of daily uses of short-acting β-agonist (SABA) used to treat asthma attacks. Uses decreased by 0.41 for the connected group and 0.31 for the control group. Plus, the number of days with no asthma attacks increased by 21% for the connected group compared with 17% for the control group.
What's more, those adults with severe uncontrolled asthma in the connected group showed a significantly greater increase in their Asthma Control Test scores than those in the control group.
The Propeller system was last year given the green light by the Food and Drug Administration (FDA) for sale in the USA.
With May 3 marking World Asthma Day, lung specialists remind asthma patients that inhalers must be used correctly to ensure a sufficient dose of medication reaches the airways.
Click here to find out more about the Propeller Health Asthma Platform
Propeller connected inhaler helps manage asthma and reduce attacks
Propeller is a smart inhaler system designed to help asthma sufferers better manage their condition by providing real-time health analytics.
This new technology has been tested in a clinical trial on 495 patients suffering from chronic asthma. As Tuesday, May 3, marks World Asthma Day, lung specialists remind sufferers that correct inhaler use plays an important role in controlling the condition.
There aren't many connected devices out there specifically targeting asthma patients. However, with almost six in 10 asthma sufferers having poor control of the condition, a high-tech device giving real-time feedback could help patients monitor and manage their treatment, pinpoint triggers and identify patterns in the aim of reducing attacks.
That's what a new intelligent inhaler system, developed by American company Propeller Health, hopes to achieve. There are three similar products currently on the market: the Nexus 6 SmartTouch, a smartphone-connected inhaler monitor; the Inspiro Medical Inspiromatic from Opko; and the CareTRx from GeckoCap, designed for children.
Propeller is an asthma management platform that uses sensors, mobile applications and location data, as well as processing algorithms to collect and analyze health data in real time. Sensors connect the inhaler to a smartphone (iOS or Android), where patients can receive notifications and advice based on real-time analytics.
Data can then be shared with a doctor or family members who can find out where the patient is if they're having an attack.
This small device was tested in a clinical trial of 495 patients suffering from chronic asthma who were monitored over a 12-month period. Participants were split into two parallel groups. All had their inhalers equipped with Propeller sensors, but only one group received electronic notifications and feedback from the insights system. Doctors of those in the connected group also had access to their patients' data. Those in the control group did not.
The results showed a reduction in the number of daily uses of short-acting β-agonist (SABA) used to treat asthma attacks. Uses decreased by 0.41 for the connected group and 0.31 for the control group. Plus, the number of days with no asthma attacks increased by 21% for the connected group compared with 17% for the control group.
What's more, those adults with severe uncontrolled asthma in the connected group showed a significantly greater increase in their Asthma Control Test scores than those in the control group.
The Propeller system was last year given the green light by the Food and Drug Administration (FDA) for sale in the USA.
With May 3 marking World Asthma Day, lung specialists remind asthma patients that inhalers must be used correctly to ensure a sufficient dose of medication reaches the airways.
Click here to find out more about the Propeller Health Asthma Platform
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Trending
Latest Videos